DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Transactions / P•••••• B••••••••• I•••
••• Locked
Add-on acquisitionclosedadd-onannounced May 20, 2019closed May 20, 2019Fact
What happened
- Target
- P•••••• B••••••••• I•••
- Platform
- C•••••••add-on basis: C••••••• Completes Acquisition of Gene Therapy Leader P•••••• B••••••••• I••• for $1.2 Billion | C••••••• is held by L•••••• G•••• • P••••••• on its portfolio page; published on L•••••• G•••• • P•••••••'s own news page
- Control
- Control
- Share acquired
- unknown
- Industry
- unknown
- Target location
- unknown
- Seller kind
- unknown
- Rollover
- unknown
Values, only where disclosed
- Enterprise value
- Not disclosed
- Purchase price
- Not disclosed
- Equity value
- Not disclosed
- Target revenue
- Not disclosed
- Target EBITDA
- Not disclosed
- Multiple
- Not disclosed
Parties and roles
4 named
Buy side
- “••• Locked”
- “••• Locked”
- “••• Locked”
Side not stated
- “••• Locked”
Evidence
“••• Locked”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026